Optimus Pharma (Optimus Drugs Private Limited)

Hyderabad, India
Small Molecule API Advanced Intermediates Key Starting Materials (KSM) Regulatory Starting Materials (RSM) Drug Substance Drug Product (Formulations) CRAMS
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Optimus Pharma (Optimus Drugs Private Limited)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Hyderabad, India
Modalities
Small Molecule API, Advanced Intermediates, Key Starting Materials (KSM), Regulatory Starting Materials (RSM), Drug Substance, Drug Product (Formulations), CRAMS
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Optimus Pharma (Optimus Drugs Private Limited)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, Advanced Intermediates, Key Starting Materials (KSM), Regulatory Starting Materials (RSM), Drug Substance, Drug Product (Formulations), CRAMS
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (7 modalities)

Frequently Asked Questions About Optimus Pharma (Optimus Drugs Private Limited)

What is Optimus Pharma (Optimus Drugs Private Limited)'s CDMO Signal Score?
Optimus Pharma (Optimus Drugs Private Limited) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Optimus Pharma (Optimus Drugs Private Limited) for a manufacturing program?
Use the free AI matchmaker to compare Optimus Pharma (Optimus Drugs Private Limited) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Torrent Pharmaceuticals Limited
Ahmedabad, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Generic Drug Products, CDMO (via JB Pharma acquisition)
Aarti Pharmalabs Limited
Mumbai, India
Small Molecule API, Steroid / Corticosteroid API, HPAPI, Anti-cancer / Cytotoxic API, Xanthine Derivatives, NCE Drug Substance
Laurus Labs
Hyderabad, India
Small Molecule API, Finished Dosage Form (FDF), CDMO (small molecule), Biologics / Large Molecule, Microbial Fermentation, Peptide API, Cell & Gene Therapy (early-stage investment), Anti-retroviral API, Oncology API, ADC (emerging)